LINEAGE CELL THERAPEUTICS IN's ticker is LCTX and the CUSIP is 53566P109. A total of 115 filers reported holding LINEAGE CELL THERAPEUTICS IN in Q2 2021. The put-call ratio across all filers is 0.65 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $15,340 | -16.3% | 13,000 | 0.0% | 0.00% | -20.0% |
Q2 2023 | $18,330 | -6.0% | 13,000 | 0.0% | 0.01% | 0.0% |
Q1 2023 | $19,500 | +28.2% | 13,000 | 0.0% | 0.01% | +25.0% |
Q4 2022 | $15,210 | +1.4% | 13,000 | 0.0% | 0.00% | -20.0% |
Q3 2022 | $15,000 | -28.6% | 13,000 | 0.0% | 0.01% | -16.7% |
Q2 2022 | $21,000 | +5.0% | 13,000 | 0.0% | 0.01% | +20.0% |
Q1 2022 | $20,000 | -37.5% | 13,000 | 0.0% | 0.01% | -37.5% |
Q4 2021 | $32,000 | -3.0% | 13,000 | 0.0% | 0.01% | -11.1% |
Q3 2021 | $33,000 | -10.8% | 13,000 | 0.0% | 0.01% | -10.0% |
Q2 2021 | $37,000 | +19.4% | 13,000 | 0.0% | 0.01% | 0.0% |
Q1 2021 | $31,000 | +72.2% | 13,000 | +30.0% | 0.01% | +66.7% |
Q4 2020 | $18,000 | – | 10,000 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
BROADWOOD CAPITAL INC | 34,935,485 | $39,477,000 | 3.01% |
Raffles Associates | 2,080,536 | $2,351,000 | 2.51% |
Defender Capital, LLC. | 5,184,035 | $5,862,000 | 2.30% |
Prescott General Partners LLC | 1,851,851 | $2,093,000 | 0.16% |
DAFNA Capital Management LLC | 140,000 | $158,000 | 0.04% |
Fort Sheridan Advisors LLC | 83,931 | $95,000 | 0.03% |
Long Focus Capital Management, LLC | 215,000 | $243,000 | 0.02% |
XTX Topco Ltd | 72,807 | $82,000 | 0.02% |
Ergoteles LLC | 490,895 | $555,000 | 0.02% |
Beirne Wealth Consulting Services, LLC | 45,000 | $51,000 | 0.02% |